Medicare Enrolled
Dr. Deborah Galloway, M.D.
Neurology · Stony Brook, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Galloway from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Galloway?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Galloway
Dr. Deborah Galloway is a neurology specialist in Stony Brook, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Galloway performed 5,262 Medicare services across 1,059 unique beneficiaries.
Between the years covered by Open Payments, Dr. Galloway received a total of $8,036 from 52 pharmaceutical and/or device companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Galloway is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NY
$8,036 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,262
Medicare services
Top 12% in NY for neurology
1,059
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~263 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
3,810 | $5 | $33 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
412 | $91 | $810 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $110 | $1,225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
241 | $82 | $878 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
114 | $193 | $2,060 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
94 | $104 | $1,106 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
89 | $228 | $2,409 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
73 | $51 | $539 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $150 | $1,848 |
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
37 | $0 | $250 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
35 | $154 | $1,574 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $84 | $720 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $13 | $204 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,036
Total received (2018-2024)
Avg $1,339/year across 6 years
Top 27% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
346
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,016 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,246
2023
$2,457
2022
$1,353
2021
$267
2019
$349
2018
$364
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$973
Medtronic, Inc.
$300
Neurocrine Biosciences, Inc.
$285
PFIZER INC.
$266
Lundbeck LLC
$225
SCILEX PHARMACEUTICALS INC.
$133
Amneal Pharmaceuticals LLC
$132
MITSUBISHI TANABE PHARMA AMERICA, INC.
$96
Kyowa Kirin, Inc.
$94
Octapharma USA, Inc.
$84
ACADIA Pharmaceuticals Inc
$64
JAZZ PHARMACEUTICALS INC.
$53
Acorda Therapeutics, Inc
$50
Grifols USA, LLC
$50
HARMONY BIOSCIENCES LLC
$49
TG Therapeutics, Inc.
$38
ARGENX US, INC.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$30
Amgen Inc.
$29
Inspire Medical Systems, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
Axsome Therapeutics, Inc.
$26
UCB, Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
Harmony Biosciences Llc
$26
Microtransponder, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
CSL Behring
$20
PROTEGA PHARMACEUTIALS INC
$15
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,386
Lundbeck LLC
$610
Sunovion Pharmaceuticals Inc.
$588
Neurocrine Biosciences, Inc.
$578
PFIZER INC.
$346
Amneal Pharmaceuticals LLC
$323
Medtronic, Inc.
$300
Kyowa Kirin, Inc.
$231
UCB, Inc.
$206
Alexion Pharmaceuticals, Inc.
$193
Amgen Inc.
$160
Teva Pharmaceuticals USA, Inc.
$154
SCILEX PHARMACEUTICALS INC.
$133
Biohaven Pharmaceutical Holding Company Ltd.
$124
Grifols USA, LLC
$121
MannKind Corporation
$119
Intuity Medical Inc
$115
Harmony Biosciences LLC
$107
MITSUBISHI TANABE PHARMA AMERICA, INC.
$96
Acorda Therapeutics, Inc
$86
Octapharma USA, Inc.
$84
ACADIA Pharmaceuticals Inc
$77
JAZZ PHARMACEUTICALS INC.
$69
Almatica Pharma LLC
$60
Takeda Pharmaceuticals U.S.A., Inc.
$54
HARMONY BIOSCIENCES LLC
$49
IMPEL PHARMACEUTICALS INC.
$48
CATALYST PHARMACEUTICALS, INC.
$40
TG Therapeutics, Inc.
$38
ARGENX US, INC.
$33
Neurelis, Inc.
$29
Inspire Medical Systems, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
UPSHER-SMITH LABORATORIES LLC
$27
Lilly USA, LLC
$26
Axsome Therapeutics, Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
Harmony Biosciences Llc
$26
ANI Pharmaceuticals, Inc.
$26
Microtransponder, Inc.
$25
Abbott Laboratories
$24
GENZYME CORPORATION
$23
Biogen, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$22
Scilex Pharmaceuticals Inc.
$21
AstraZeneca Pharmaceuticals LP
$21
CSL Behring
$20
Catalyst Pharmaceuticals, Inc.
$20
SK Life Science, Inc.
$18
Horizon Therapeutics plc
$18
GRT US Holding, Inc.
$18
PROTEGA PHARMACEUTIALS INC
$15
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · AMVUTTRA · APTIOM · AUBAGIO · Aimovig · BOTOX · BRIUMVI · Briviact · COMIRNATY · DAXXIFY · EMGALITY · FIRDAPSE · FYCOMPA · Fintepla · GRALISE · Gamunex-C · HYQVIA · INBRIJA · INFINITY · INGREZZA · INSPIRE · Kcentra · NUPLAZID · NURTEC ODT · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PLEGRIDY · PURIFIED CORTROPHIN GEL · Pogo Automatic Blood Glucose Monitoring System · QULIPTA · Qutenza · RADICAVA · REXULTI · ROXYBOND · RYTARY · Rystiggo · SOLIRIS · Sunosi · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VYEPTI · VYVGART · WAKIX · XYWAV · ZEMBRACE SYMTOUCH · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
174
Per 100K population
11.4
County median income
$128,329
Nearest hospital
SUNY/STONY BROOK UNIVERSITY HOSPITAL
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Galloway is a mixed practice specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Galloway experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Galloway performed 3,810 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Galloway receive payments from pharmaceutical companies?
Yes. Dr. Galloway received a total of $8,036 from 52 companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Galloway's costs compare to other neurologists in Stony Brook?
Dr. Galloway's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Galloway) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Stony Brook
Browse neurologists in Stony Brook ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology